← Back to Discover
Darwin Global Management, Ltd.
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $3,760,253,505
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- REVOLUTION MEDICINES INC · COM · 76155X100 · shares: $2,047,516,314
- INSMED INC · COM PAR $.01 · 457669307 · shares: $673,600,013
- BELITE BIO INC · SPONSORED ADS · 07782B104 · shares: $456,588,244
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares: $348,215,205
- ROIVANT SCIENCES LTD · SHS · G76279101 · shares: $234,333,729
Reported holdings
5 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| REVOLUTION MEDICINES INC | COM | 76155X100 | — | 10,629,822 shares | $2,047,516,314 |
| INSMED INC | COM PAR $.01 | 457669307 | — | 6,431,163 shares | $673,600,013 |
| BELITE BIO INC | SPONSORED ADS | 07782B104 | — | 3,077,219 shares | $456,588,244 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | — | 3,621,583 shares | $348,215,205 |
| ROIVANT SCIENCES LTD | SHS | G76279101 | — | 6,747,300 shares | $234,333,729 |